Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.

Massicano AVF, Lee S, Crenshaw BK, Aweda TA, El Sayed R, Super I, Bose R, Marquez-Nostra BV, Lapi SE.

Cancer Biother Radiopharm. 2019 Jan 24. doi: 10.1089/cbr.2018.2654. [Epub ahead of print]

PMID:
30676778
2.

Spinal cord stimulation for complex regional pain syndrome type I with spinal myoclonus - a case report and review of literature.

Bose R, Banerjee AD.

Br J Neurosurg. 2019 Jan 12:1-3. doi: 10.1080/02688697.2018.1552755. [Epub ahead of print]

PMID:
30636459
3.

Phrenic nerve stimulation for diaphragmatic pacing in chronic ventilator-dependent patients.

Bose R, Banerjee AD, Brajesh V, Narang KS, Dubey S, Singh VP.

Neurol India. 2018 Nov-Dec;66(6):1834-1837. doi: 10.4103/0028-3886.246256. No abstract available.

4.

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Nov 14;9(1):4850. doi: 10.1038/s41467-018-07407-3.

5.

Accomplishments and challenges in stem cell imaging in vivo.

Bose RJC, Mattrey RF.

Drug Discov Today. 2018 Oct 17. pii: S1359-6446(18)30151-X. doi: 10.1016/j.drudis.2018.10.007. [Epub ahead of print] Review.

PMID:
30342245
6.

Evaluation of the quality of transesophageal echocardiography images and verification of proficiency

Matyal R, Mahmood F, Knio ZO, Jones SB, Yeh L, Amir R, Bose R, Mitchell JD.

Echo Res Pract. 2018 Sep 1;5(3):89-95. doi: 10.1530/ERP-18-0002.

7.

Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia.

Bose RJ, Kim BJ, Arai Y, Han IB, Moon JJ, Paulmurugan R, Park H, Lee SH.

Biomaterials. 2018 Dec;185:360-370. doi: 10.1016/j.biomaterials.2018.08.018. Epub 2018 Aug 9.

PMID:
30273835
8.

Regulation of Transcription by Circular RNAs.

Bose R, Ain R.

Adv Exp Med Biol. 2018;1087:81-94. doi: 10.1007/978-981-13-1426-1_7. Review.

PMID:
30259359
9.

Spatio-temporal patterns of orchids flowering in Cameroonian rainforests.

Texier N, Deblauwe V, Stévart T, Sonké B, Simo-Droissart M, Azandi L, Bose R, Djuikouo MN, Kamdem G, Kamdem N, Mayogo S, Zemagho L, Droissart V.

Int J Biometeorol. 2018 Nov;62(11):1931-1944. doi: 10.1007/s00484-018-1594-3. Epub 2018 Sep 13.

PMID:
30215186
10.

The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Sep 4;9(1):3476. doi: 10.1038/s41467-018-05914-x. Erratum in: Nat Commun. 2018 Nov 14;9(1):4850.

11.

Reply to J.J. Tao et al.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Aug 10;36(23):2451. doi: 10.1200/JCO.2018.78.6392. Epub 2018 Jun 1. No abstract available.

PMID:
29856693
12.

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.

Gullo G, Walsh N, Fennelly D, Bose R, Walshe J, Tryfonopoulos D, O'Mahony K, Hammond L, Silva N, McDonnell D, Ballot J, Quinn C, McDermott EW, Evoy D, Prichard R, Geraghty J, Amstrong J, Crown J.

Br J Cancer. 2018 Aug;119(3):374-380. doi: 10.1038/s41416-018-0114-x. Epub 2018 May 18.

PMID:
29773838
13.

Evaluation of the quality of transesophageal echocardiography images and verification of proficiency.

Matyal R, Mahmood F, Knio ZO, Jones S, Yeh L, Amir R, Bose R, Mitchell JD.

Echo Res Pract. 2018 May 9. pii: ERP-18-0002. doi: 10.1530/ERP-18-0002. [Epub ahead of print]

14.

Biological Response to Time-Controlled Adaptive Ventilation Depends on Acute Respiratory Distress Syndrome Etiology.

Silva PL, Cruz FF, Samary CDS, Moraes L, de Magalhães RF, Fernandes MVS, Bose R, Pelegati VB, Carvalho HF, Capelozzi VL, Satalin J, Gatto L, Andrews P, Habashi N, Nieman G, Rocco PRM.

Crit Care Med. 2018 Jun;46(6):e609-e617. doi: 10.1097/CCM.0000000000003078.

PMID:
29485489
15.

Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.

Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA.

Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13.

PMID:
29442264
16.

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.

Bose RJ, Paulmurugan R, Moon J, Lee SH, Park H.

Drug Discov Today. 2018 Apr;23(4):891-899. doi: 10.1016/j.drudis.2018.02.001. Epub 2018 Feb 6. Review.

PMID:
29426004
17.

Summative Objective Structured Clinical Examination Assessment at the End of Anesthesia Residency for Perioperative Ultrasound.

Mitchell JD, Amir R, Montealegre-Gallegos M, Mahmood F, Shnider M, Mashari A, Yeh L, Bose R, Wong V, Hess P, Amador Y, Jeganathan J, Jones SB, Matyal R.

Anesth Analg. 2018 Jun;126(6):2065-2068. doi: 10.1213/ANE.0000000000002826.

PMID:
29381519
18.

Decreased Clinical Severity of Strangles in Weanlings Associated with Restricted Seroconversion to Optimized Streptococcus equi ssp equi Assays.

Tscheschlok L, Venner M, Steward K, Böse R, Riihimäki M, Pringle J.

J Vet Intern Med. 2018 Jan;32(1):459-464. doi: 10.1111/jvim.15037.

19.

Phosphaplatin Anti-tumor Effect Enhanced by Liposomes Partly via an Up-regulation of PEDF in Breast Cancer.

Belkacemi L, Atkins JL, Yang LU, Gadgil P, Sater AK, Chow DS, Bose RN, Zhang SX.

Anticancer Res. 2018 Feb;38(2):623-646.

PMID:
29374685
20.

Simulation-based Assessment to Reliably Identify Key Resident Performance Attributes.

Blum RH, Muret-Wagstaff SL, Boulet JR, Cooper JB, Petrusa ER, Baker KH, Davidyuk G, Dearden JL, Feinstein DM, Jones SB, Kimball WR, Mitchell JD, Nadelberg RL, Wiser SH, Albrecht MA, Anastasi AK, Bose RR, Chang LY, Culley DJ, Fisher LJ, Grover M, Klainer SB, Kveraga R, Martel JP, McKenna SS, Minehart RD, Mitchell JD, Mountjoy JR, Pawlowski JB, Pilon RN, Shook DC, Silver DA, Warfield CA, Zaleski KL; Harvard Assessment of Anesthesia Resident Performance Research Group.

Anesthesiology. 2018 Apr;128(4):821-831. doi: 10.1097/ALN.0000000000002091.

PMID:
29369062
21.

Sox2 is required for olfactory pit formation and olfactory neurogenesis through BMP restriction and Hes5 upregulation.

Panaliappan TK, Wittmann W, Jidigam VK, Mercurio S, Bertolini JA, Sghari S, Bose R, Patthey C, Nicolis SK, Gunhaga L.

Development. 2018 Jan 19;145(2). pii: dev153791. doi: 10.1242/dev.153791.

22.

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R.

J Clin Oncol. 2018 Feb 20;36(6):536-542. doi: 10.1200/JCO.2017.75.3780. Epub 2018 Jan 10. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):360.

PMID:
29320312
23.

Molybdenum Sulphoselenophosphide Spheroids as an Effective Catalyst for Hydrogen Evolution Reaction.

Bose R, Jothi VR, Koh B, Jung C, Yi SC.

Small. 2018 Feb;14(8). doi: 10.1002/smll.201703862. Epub 2018 Jan 10.

PMID:
29318738
24.

Ubiquitin Ligase Huwe1 Modulates Spermatogenesis by Regulating Spermatogonial Differentiation and Entry into Meiosis.

Bose R, Sheng K, Moawad AR, Manku G, O'Flaherty C, Taketo T, Culty M, Fok KL, Wing SS.

Sci Rep. 2017 Dec 19;7(1):17759. doi: 10.1038/s41598-017-17902-0.

25.

Analyzing text recognition from tactually evoked EEG.

Khasnobish A, Datta S, Bose R, Tibarewala DN, Konar A.

Cogn Neurodyn. 2017 Dec;11(6):501-513. doi: 10.1007/s11571-017-9452-2. Epub 2017 Sep 6.

26.

Survival trends in glioma: Experience at a tertiary care centre.

Bose R, Narang KS, Bhangale D, Kedia R, Sharma V, Jha AN.

Neurol India. 2017 Nov-Dec;65(6):1295-1301. doi: 10.4103/0028-3886.217968.

PMID:
29133704
27.

Huwe1 Regulates the Establishment and Maintenance of Spermatogonia by Suppressing DNA Damage Response.

Fok KL, Bose R, Sheng K, Chang CW, Katz-Egorov M, Culty M, Su S, Yang M, Ruan YC, Chan HC, Iavarone A, Lasorella A, Cencic R, Pelletier J, Nagano M, Xu W, Wing SS.

Endocrinology. 2017 Nov 1;158(11):4000-4016. doi: 10.1210/en.2017-00396.

PMID:
28938460
28.

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types.

Kumar RD, Bose R.

Sci Rep. 2017 Jul 25;7(1):6418. doi: 10.1038/s41598-017-06366-x.

29.

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

Ma CX, Bose R, Gao F, Freedman RA, Telli ML, Kimmick G, Winer E, Naughton M, Goetz MP, Russell C, Tripathy D, Cobleigh M, Forero A, Pluard TJ, Anders C, Niravath PA, Thomas S, Anderson J, Bumb C, Banks KC, Lanman RB, Bryce R, Lalani AS, Pfeifer J, Hayes DF, Pegram M, Blackwell K, Bedard PL, Al-Kateb H, Ellis MJC.

Clin Cancer Res. 2017 Oct 1;23(19):5687-5695. doi: 10.1158/1078-0432.CCR-17-0900. Epub 2017 Jul 5.

30.

ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.

Bose R, Karthaus WR, Armenia J, Abida W, Iaquinta PJ, Zhang Z, Wongvipat J, Wasmuth EV, Shah N, Sullivan PS, Doran MG, Wang P, Patruno A, Zhao Y; International SU2C/PCF Prostate Cancer Dream Team, Zheng D, Schultz N, Sawyers CL.

Nature. 2017 Jun 29;546(7660):671-675. doi: 10.1038/nature22820. Epub 2017 Jun 14.

31.

Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.

Bose RJC, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S, Thandavarayan RA.

Drug Discov Today. 2017 Aug;22(8):1258-1265. doi: 10.1016/j.drudis.2017.05.015. Epub 2017 Jun 8. Review.

PMID:
28600191
32.

Co-catalytic Effects of CoS2 on the Activity of the MoS2 Catalyst for Electrochemical Hydrogen Evolution.

Bose R, Jin Z, Shin S, Kim S, Lee S, Min YS.

Langmuir. 2017 Jun 13;33(23):5628-5635. doi: 10.1021/acs.langmuir.7b00580. Epub 2017 Jun 2.

PMID:
28544849
33.
34.

Valsalva maneuver aided adherent ventriculoperitoneal shunt removal.

Haldar R, Bose R, Samanta S, Das KK.

Asian J Neurosurg. 2017 Apr-Jun;12(2):339-340. doi: 10.4103/1793-5482.145536. No abstract available.

35.

Ultrasound as a Screening Tool for Central Venous Catheter Positioning and Exclusion of Pneumothorax.

Amir R, Knio ZO, Mahmood F, Oren-Grinberg A, Leibowitz A, Bose R, Shaefi S, Mitchell JD, Ahmed M, Bardia A, Talmor D, Matyal R.

Crit Care Med. 2017 Jul;45(7):1192-1198. doi: 10.1097/CCM.0000000000002451.

PMID:
28422778
36.

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.

Griffith M, Spies NC, Krysiak K, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, Jones MR, Bilski RL, Lesurf R, Feng YY, Shah NM, Bonakdar M, Trani L, Matlock M, Ramu A, Campbell KM, Spies GC, Graubert AP, Gangavarapu K, Eldred JM, Larson DE, Walker JR, Good BM, Wu C, Su AI, Dienstmann R, Margolin AA, Tamborero D, Lopez-Bigas N, Jones SJ, Bose R, Spencer DH, Wartman LD, Wilson RK, Mardis ER, Griffith OL.

Nat Genet. 2017 Jan 31;49(2):170-174. doi: 10.1038/ng.3774. No abstract available.

37.

The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses.

Cabrita MA, Bose R, Vanzyl EJ, Pastic A, Marcellus KA, Pan E, Hamill JD, McKay BC.

Gene. 2017 Apr 15;608:86-94. doi: 10.1016/j.gene.2017.01.018. Epub 2017 Jan 21.

PMID:
28119089
38.

Efficient sortase-mediated N-terminal labeling of TEV protease cleaved recombinant proteins.

Sarpong K, Bose R.

Anal Biochem. 2017 Mar 15;521:55-58. doi: 10.1016/j.ab.2017.01.008. Epub 2017 Jan 11.

39.

Tiny molecule, big power: Multi-target approach for curcumin in diabetic cardiomyopathy.

Karuppagounder V, Arumugam S, Giridharan VV, Sreedhar R, Bose RJ, Vanama J, Palaniyandi SS, Konishi T, Watanabe K, Thandavarayan RA.

Nutrition. 2017 Feb;34:47-54. doi: 10.1016/j.nut.2016.09.005. Epub 2016 Sep 30. Review.

PMID:
28063511
40.

Four-Dimensional Ultrafast Electron Microscopy: Insights into an Emerging Technique.

Adhikari A, Eliason JK, Sun J, Bose R, Flannigan DJ, Mohammed OF.

ACS Appl Mater Interfaces. 2017 Jan 11;9(1):3-16. doi: 10.1021/acsami.6b12301. Epub 2017 Jan 3.

PMID:
27976852
41.

Effect of the Dianhydride/Branched Diamine Ratio on the Architecture and Room Temperature Healing Behavior of Polyetherimides.

Susa A, Bose RK, Grande AM, van der Zwaag S, Garcia SJ.

ACS Appl Mater Interfaces. 2016 Dec 14;8(49):34068-34079. Epub 2016 Nov 30.

PMID:
27960394
42.

Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.

Keppel TR, Sarpong K, Murray EM, Monsey J, Zhu J, Bose R.

J Biol Chem. 2017 Jan 13;292(2):597-610. doi: 10.1074/jbc.M116.747485. Epub 2016 Nov 21.

43.

Analysis of distribution of DNA methylation in kidney-renal-clear-cell-carcinoma specific genes using entropy.

Ramakrishnan N, Bose R.

Genom Data. 2016 Oct 18;10:109-113. eCollection 2016 Dec.

44.

Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications.

Bose RJ, Lee SH, Park H.

Biomater Res. 2016 Oct 31;20:34. eCollection 2016. Review.

45.

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.

Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F.

Mol Imaging Biol. 2016 Dec;18(6):952-959.

46.

Shape-Tunable Charge Carrier Dynamics at the Interfaces between Perovskite Nanocrystals and Molecular Acceptors.

Ahmed GH, Liu J, Parida MR, Murali B, Bose R, AlYami NM, Hedhili MN, Peng W, Pan J, Besong TM, Bakr OM, Mohammed OF.

J Phys Chem Lett. 2016 Oct 6;7(19):3913-3919. Epub 2016 Sep 22.

PMID:
27640429
47.

Unsupervised detection of cancer driver mutations with parsimony-guided learning.

Kumar RD, Swamidass SJ, Bose R.

Nat Genet. 2016 Oct;48(10):1288-94. doi: 10.1038/ng.3658. Epub 2016 Sep 12.

48.

Insights into the anti-angiogenic properties of phosphaplatins.

Yang L, Moghaddas S, Dezvareh H, Belkacemi L, Bark SJ, Bose RN, Do LH.

J Inorg Biochem. 2016 Nov;164:5-16. doi: 10.1016/j.jinorgbio.2016.07.020. Epub 2016 Jul 27.

PMID:
27591123
49.

Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments.

Bose RJ, Lee SH, Park H.

Drug Discov Today. 2016 Aug;21(8):1303-12. doi: 10.1016/j.drudis.2016.06.005. Epub 2016 Jun 11. Review.

PMID:
27297732
50.

Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.

Ross JS, Gay LM, Wang K, Ali SM, Chumsri S, Elvin JA, Bose R, Vergilio JA, Suh J, Yelensky R, Lipson D, Chmielecki J, Waintraub S, Leyland-Jones B, Miller VA, Stephens PJ.

Cancer. 2016 Sep 1;122(17):2654-62. doi: 10.1002/cncr.30102. Epub 2016 Jun 10.

Supplemental Content

Support Center